Operating Assets and Liabilities
12 Months Ended
Dec. 31, 2017
Operating Assets and Liabilities  
Operating Assets and Liabilities

Section 4—Operating Assets and Liabilities

4.1   Equipment

                                                                                                                                                                                    

 

 

Equipment

 

 

 

USD '000

 

Cost:

 

 

 

 

At January 1, 2016

 

 

401

 

Additions

 

 

31

 

Disposals

 

 

(3

)

Exchange differences

 

 

(15

)

​  

​  

At December 31, 2016

 

 

414

 

Additions

 

 

3

 

Disposals

 

 

(363

)

Exchange difference

 

 

12

 

​  

​  

At December 31, 2017

 

 

66

 

​  

​  

​  

​  

Accumulated Depreciation:

 

 

 

 

At January 1, 2016

 

 

49

 

Depreciation charge for the year

 

 

109

 

Disposals

 

 

(3

)

Exchange difference

 

 

(9

)

​  

​  

At December 31, 2016

 

 

146

 

Depreciation charge for the year

 

 

19

 

Disposals

 

 

(363

)

Impairment (see below)

 

 

208

 

Exchange difference

 

 

44

 

​  

​  

At December 31, 2017

 

 

54

 

​  

​  

​  

​  

Net book value:

 

 

 

 

At December 31, 2016

 

 

268

 

​  

​  

​  

​  

At December 31, 2017

 

 

12

 

​  

​  

​  

​  

         Depreciation expense included within operating results for each of the years ended December 31, 2017, 2016 and 2015 is as follows:

                                                                                                                                                                                    

 

 

Year Ended December 31,

 

 

 

2017

 

2016

 

2015

 

 

 

USD '000

 

USD '000

 

USD '000

 

Research and development costs

 

 

224

 

 

106

 

 

34

 

General and administrative costs

 

 

3

 

 

3

 

 

3

 

​  

​  

​  

​  

​  

​  

Total

 

 

227

 

 

109

 

 

37

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

         As discussed in Note 1.1, the Company announced on March 1, 2017 a plan to reduce costs and wind-down research and development efforts of FP187®. In connection with winding down of research and development efforts, certain equipment that had been used in the development of FP187® was deemed impaired. Accordingly, during the year ended December 31, 2017, the Group recognized an impairment expense of $208,000 that is included in the above table within research and development costs.

4.2   Prepaid expenses

                                                                                                                                                                                    

 

 

December 31,

 

 

 

2017

 

2016

 

 

 

USD '000

 

USD '000

 

Advanced payments to contract research and manufacturing organizations

 

 

 

 

132

 

Insurance

 

 

421

 

 

450

 

Other

 

 

81

 

 

74

 

​  

​  

​  

​  

Total

 

 

502

 

 

656

 

​  

​  

​  

​  

​  

​  

​  

​  

4.3   Other receivables

                                                                                                                                                                                    

 

 

December 31,

 

 

 

2017

 

2016

 

 

 

USD '000

 

USD '000

 

VAT receivables

 

 

513

 

 

305

 

Accrued interest income

 

 

 

 

117

 

Other receivables

 

 

5

 

 

5

 

​  

​  

​  

​  

Total

 

 

518

 

 

427

 

​  

​  

​  

​  

​  

​  

​  

​  

4.4   Accrued liabilities

                                                                                                                                                                                    

 

 

December 31,

 

 

 

2017

 

2016

 

 

 

USD '000

 

USD '000

 

Accrued amounts due in accordance with the Amendment (Note 3.4)

 

 

11,757

 

 

 

Professional advisors

 

 

910

 

 

4,042

 

Contract research and manufacturing organizations

 

 

77

 

 

715

 

Other

 

 

299

 

 

310

 

​  

​  

​  

​  

Total

 

 

13,043

 

 

5,067

 

​  

​  

​  

​  

​  

​  

​  

​